Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Tech

>> WITH Latest News

AUG 18, 2013 - ScienceDaily

A Must Read - Share

Type 1 diabetes study identifies subset of patients with strong response to therapy

Primary results from a new clinical trial show that a discrete subset of patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) demonstrated especially robust response with greater preservation of C-peptide, a biomarker of islet cell function, compared to controls, suggesting that these patients could be identified prior to treatment.

Tags: Type 1 diabetes study identifies subset of patients with strong response to therapy,  With Latest News